Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
Group Sign-on Letter Concerning the VALID Act of 2022 Discussion Draft
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act
-
Sign-on Letter Concerning Patent Legislation Negotiation Process
-
Group Letter Opposing Section 2527(b) of the US Innovation and Competition Act (USICA)
-
Group Sign-on Letter to CMS Regarding Split or Shared Visits
-
Group Sign-on Letter to Congress Supporting the Reducing Hereditary Cancer Act
-
Group Sign-On Letter Regarding Telehealth Extension Legislation
-
Amicus brief for HHS v Louisiana Stay (SCOTUS) – CMS Vaccination Requirements
-
Amicus Brief for Biden v Missouri Stay (CA8) – CMS Vaccination Requirements